Press Releases November 02
Swire Pacific Limited
00019.HK 00087.HK
Swire Properties Outlines HK$15 Billion Investment Plan To Advance "One Taikoo" ...
Swire Pacific Limited
00019.HK 00087.HK
Swire Properties Outlines HK$15 Billion Investment Plan To Advance "One Taikoo" ...
Announcements / Notices November 02
Walnut Capital Limited
00905.HK
INSIDE INFORMATION (1) PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER; (2) ...
Walnut Capital Limited
00905.HK
INSIDE INFORMATION (1) PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER; (2) ...
Announcements / Notices November 02
Jufeel International Holdings Limited
08611.HK
RESIGNATION OF AUDITOR
Jufeel International Holdings Limited
08611.HK
RESIGNATION OF AUDITOR
Returns on Share Capital November 02
TCL Electronics Holdings Limited
01070.HK
NEXT DAY DISCLOSURE RETURN-CHANGES IN ISSUED SHARE CAPITAL
TCL Electronics Holdings Limited
01070.HK
NEXT DAY DISCLOSURE RETURN-CHANGES IN ISSUED SHARE CAPITAL
Announcements / Notices November 02
Lotus Horizon Holdings Limited
06063.HK
UPDATE ON STATUS OF PUBLIC FLOAT AND GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE ...
Lotus Horizon Holdings Limited
06063.HK
UPDATE ON STATUS OF PUBLIC FLOAT AND GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE ...
Returns on Share Capital November 02
Dawnrays Pharmaceutical (Holdings) Limited
02348.HK
Next Day Disclosure Return
Dawnrays Pharmaceutical (Holdings) Limited
02348.HK
Next Day Disclosure Return
Announcements / Notices November 02
CSPC Pharmaceutical Group Limited
01093.HK
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF PRUSOGLIPTIN TABLETS IN COMBINATION ...
CSPC Pharmaceutical Group Limited
01093.HK
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF PRUSOGLIPTIN TABLETS IN COMBINATION ...
Announcements / Notices November 02
CSPC Pharmaceutical Group Limited
01093.HK
VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6052 (RECOMBINANT HERPES ZOSTER ...
CSPC Pharmaceutical Group Limited
01093.HK
VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6052 (RECOMBINANT HERPES ZOSTER ...
Announcements / Notices November 02
CSPC Pharmaceutical Group Limited
01093.HK
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYS6057 (RECOMBINANT RESPIRATORY ...
CSPC Pharmaceutical Group Limited
01093.HK
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYS6057 (RECOMBINANT RESPIRATORY ...


















